Emerging Infectious Diseases (Jul 2022)

Targeted Screening for Chronic Q Fever, the Netherlands

  • Daphne F.M. Reukers,
  • Pieter T. de Boer,
  • Alfons O. Loohuis,
  • Peter C. Wever,
  • Chantal P. Bleeker-Rovers,
  • Arianne B. van Gageldonk-Lafeber,
  • Wim van der Hoek,
  • Aura Timen

DOI
https://doi.org/10.3201/eid2807.212273
Journal volume & issue
Vol. 28, no. 7
pp. 1403 – 1409

Abstract

Read online

Early detection of and treatment for chronic Q fever might prevent potentially life-threatening complications. We performed a chronic Q fever screening program in general practitioner practices in the Netherlands 10 years after a large Q fever outbreak. Thirteen general practitioner practices located in outbreak areas selected 3,419 patients who had specific underlying medical conditions, of whom 1,642 (48%) participated. Immunofluorescence assay of serum showed that 289 (18%) of 1,642 participants had a previous Coxiella burnetii infection (IgG II titer >1:64), and 9 patients were suspected of having chronic Q fever (IgG I y titer >1:512). After medical evaluation, 4 of those patients received a chronic Q fever diagnosis. The cost of screening was higher than estimated earlier, but the program was still cost-effective in certain high risk groups. Years after a large Q fever outbreak, targeted screening still detected patients with chronic Q fever and is estimated to be cost-effective.

Keywords